1355 DM919, an IND-ready MICA/B-specific antibody, reinforces NKG2D-MICA/B axis and promotes anti-tumor activities

• Yi Xu,
• Dong Zhang,
• Nan Bing,
• Hong Chang,
• Sheng Yin,
• Guangan Hu,
• Quanju Zhao,
• Xiaochun Chen,
• Xiaodong Jiang

Affiliations

Yi Xu

2D2M Biotherapeutics, Suzhou, Jiangsu, China

Dong Zhang

1D2M Biotherapeutics, Natick, MA, USA

Nan Bing

1D2M Biotherapeutics, Natick, MA, USA

Hong Chang

2D2M Biotherapeutics Co., Suzhou, Jiangsu, China

Sheng Yin

2D2M Biotherapeutics Co., Suzhou, Jiangsu, China

Guangan Hu

1D2M Biotherapeutics, Natick, MA, USA

Quanju Zhao

1D2M Biotherapeutics, Natick, MA, USA

Xiaochun Chen

1D2M Biotherapeutics, Natick, MA, USA

Xiaodong Jiang

1D2M Biotherapeutics, Natick, MA, USA